Brittany Brown, NP
Adult Health · Lynchburg, VANPI 1295328987
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,060 of the $14,317 with a category attached, or 84.2%. AbbVie accounts for 93.6% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $9,460 and has fallen 63.0% since, to $3,504 in 2025. Among adult health clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 115 payments — averaging $124.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$13K
- UCB, Inc.$241
- Lundbeck LLC$108
- Lilly USA, LLC$94
- SK Life Science, Inc.$66
- Amgen$57
- plus $357 from 13 others
What the payments were for
- Speaking & faculty fees$12,06084%
- Travel & lodging$5514%
- Food & beverage$1,65612%
- Education$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $13,394 |
| UCB, Inc. | 22 | $241 |
| Lundbeck LLC | 5 | $108 |
| Lilly USA, LLC | 5 | $94 |
| SK Life Science, Inc. | 3 | $66 |
| Amgen | 3 | $57 |
| Impel Pharmaceuticals Inc. | 3 | $51 |
| AstraZeneca | 1 | $50 |
| Neurelis, Inc. | 3 | $43 |
| Bard Peripheral Vascular, Inc. | 1 | $39 |
| Biogen | 2 | $39 |
| Medtronic | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $19 |
| Upsher-smith Laboratories LLC | 1 | $18 |
| Pfizer | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,317 in reported general payments places this provider in the 95th percentile of 368 adult health providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,842 |
| Donepezil Hcl | 42 | $590 |
| Levetiracetam | 25 | $435 |
| Memantine Hcl | 27 | $277 |
Paid to pharmacies, not to this prescriber.
Other adult health in Lynchburg
- Alexis McKinneyLynchburg$4K
- Christine KesslerFort Belvoir$107K
- Denise BruenCharlottesville$45K
- Theresa Harrington StukusFairfax$40K
- Chelsea KoskovichFredericksburg$34K
- Colleen DieringVirginia Beach$13K
- Veronica HughesRichmond$12K
- Nicole SellersNorfolk$12K
- Amy WenzelMechanicsville$11K
- Robert GrossmanDanville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.